myLaminin Perspectives

The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.

Clinical trial start-up delays continue to impact site activation, budgets, and timelines due to fragmented workflows across feasibility, contracting, IRB/REB approvals, training, and system readiness. This article explains how CTMS platforms, integrated research systems, and AI-driven automation reduce inefficiencies by centralizing processes, improving visibility, and accelerating trial activation across global clinical research environments.

Interdisciplinary and cross-jurisdictional research, especially in healthcare and social sciences, creates significant Research Data Management (RDM) challenges. Disconnected tools increase compliance risk, data loss, and inefficiency. This article explores how a centralized RDM platform supports secure collaboration, embeds governance across the research data lifecycle, enables standardization, and reduces regulatory risk so research teams can focus on discovery, not data ch

Managing and protecting health information is both a legal and ethical obligation for healthcare and research institutions. HIPAA, the Health Insurance Portability and Accountability Act, sets federal standards to safeguard Protected Health Information (PHI). It gives individuals rights over their data, restricts disclosure, and requires safeguards. Covered entities and business associates, such as research platforms, must comply through privacy, security, and breach notifica